Opioid Agonist Therapy linked to increased HCV treatment rates in people who inject drugs
Series: Infectious Disease AdvisorNew York Infectious Disease Advisor 2021Description: 2p. article reviewSubject(s): Online resources: Summary: Findings of a large Canadian retrospective longitudinal cohort study published in Clinical Infectious Diseases. Although injection drug users have a disproportionately high rate of HCV compared with the general population in Canada, their rate of HCV treatment initiation remains lower than the general population, the authors wrote.Item type | Current library | Call number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|
Online journal/article | Library Online | Available |
English
Findings of a large Canadian retrospective longitudinal cohort study published in Clinical Infectious Diseases. Although injection drug users have a disproportionately high rate of HCV compared with the general population in Canada, their rate of HCV treatment initiation remains lower than the general population, the authors wrote.